VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
XtalPi Holdings (HK:02228) Secures $400M+ AI Drug Discovery Deal with Global Pharma Giant for GPCR Oral Therapeutics
XtalPi Holdings (HK:02228) Secures $400M+ AI Drug Discovery Deal with Global Pharma Giant for GPCR Oral Therapeutics
Jun 09, 2026 22:30 CST Updated Jun 11, 14:30
Share:
